Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Kongo vs Mevo Health

Kongo
Graded #27

Higher grade

vs+23.599999999999994
Mevo Health
Graded #327

Lower grade

The verdict

Kongo takes it — 83.8/100 to 60.2/100.

Kongo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Cheap semaglutide ($119) but a steeper tirzepatide step-up ($229); verified, nationwide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueKongo +30
86
56
Dose & formulationMevo Health +3
80
83
Clinical oversightKongo +17
84
67
Labs & monitoringKongo +30
82
52
FulfillmentKongo +30
87
57
Contract termsKongo +65
85
20
Kongo · left barMevo Health · right bar

The numbers

MetricKongoMevo Health
WeighScore83.8/10060.2/100
GradeBC
Scorecard rank#27#327
Semaglutide$119/mo$199/mo (all doses, compounded)
Tirzepatide$229/mo$259/mo (all doses, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Kongo

Graded #27 · B

Strengths

  • $119 semaglutide
  • All 50 states, LegitScript-verified
  • Both molecules

Where it loses points

  • Tirzepatide jumps to $229/mo
  • Injection-only
  • Monitoring detail sparse
Mevo Health

Graded #327 · C

Strengths

  • LegitScript verification badge on multiple pages
  • Publishes the FDA compounded-medication disclaimer
  • Four named board-certified physicians disclosed (Wasef, Suppa, Sakla, Chikando)
  • Both semaglutide and tirzepatide in injection and oral-tablet forms — rare in DTC
  • Public entry-level pricing surfaced

Where it loses points

  • States served not listed on any public page
  • Pharmacy partners not named (only '503A U.S. compounding pharmacies' with unlabeled logos)
  • No formal Medical Director role disclosed
  • Only 'as low as' entry pricing shown — no per-dose itemization
  • No SOC 2 certification claimed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard